2018 Conferences and Events > Fourth Joint Conference of BHIVA with BASHH (Edinburgh 2018) > Fourth Joint Conference of BHIVA with BASHH - Presentations >

Fourth Joint Conference of BHIVA with BASHH - Thursday 19 April 2018

Fourth Joint Conference of BHIVA with BASHH (Edinburgh 2018)Date: 17-20 April 2018

Venue: Edinburgh International Conference Centre, UK

Presentations

Please view and download conference presentations by clicking on the links below:

To view presentations from the Hepatology Highlights for the Healthcare Specialist in collaboration with BVHG, held on Tuesday 17 April 2018, click here.

Launch: BHIVA Standards of Care For People Living with HIV

Dr Ann Sullivan Welcome and Introduction
Dr Ann Sullivan, Chelsea and Westminster Hospital, London

Dr Alison Howarth Overview of Standards’ Development
Dr Alison Howarth, UCL Centre for Sexual Health & HIV Research

Professor Richard Harding New standard for palliative care
Professor Richard Harding, King's College London

Ms Rebecca Mbewe Patients’ perspective
Ms Rebecca Mbewe, NAZ Project London


Watch video

 

BHIVA/BASHH Guidelines Session

Dr Nicola Mackie Joint FSRH/BASHH/BHIVA guidelines for sexual and reproductive health in people living with HIV
Dr Nicola Mackie, Imperial College Healthcare NHS Trust, London

Dr Helen Fifer BASHH Mycoplasma genitalium guidelines
Dr Helen Fifer, Public Health England

Dr Tariq Sadiq BASHH gonorrhoea guidelines
Dr Tariq Sadiq, St George's, University of London

Dr Yvonne Gilleece BHIVA pregnancy guidelines
Dr Yvonne Gilleece, Brighton and Sussex University Hospitals NHS Trust


Watch video

 

HIV Oral Research Presentations: Session 3

Dr Celia Jackson Abstract O16: An outbreak of HIV amongst people who inject drugs: a phylogenetic analysis
Dr Celia Jackson, NHS Greater Glasgow and Clyde

Dr Mimi Hou Abstract O17: Viral evolution in infant HIV infection
Dr Mimi Hou, University of Oxford

Dr Genevieve Martin Abstract O18: CD32 is enriched on CD4 T-cells with a T-follicular phenotype in gut-associated lymphoid tissue but does not associate with HIV DNA
Dr Genevieve Martin, University of Oxford

Mr Davide De Francesco Abstract O19: Associations between cognitive function and cardiovascular risk factors: differences between people with HIV and HIV-negative controls
Mr Davide De Francesco, University College London

Ms Claire Petersen Abstract O20: Frequency and reasons for switching integrase inhibitor based ART
Ms Claire Petersen, Imperial College Healthcare NHS Trust, London

Dr Virginia Rasi Abstract O21: Assessing the influence of BHIVA guidelines on trends in antiretroviral use in pregnancy in the UK and Ireland in 2005–2016
Dr Virginia Rasi, University College London

Dr Marina Daskalopoulou Abstract O22: Disclosure of HIV-serostatus to new sex partners and sexual behaviours among HIV-diagnosed MSM in the UK: results from the ASTRA study
Dr Marina Daskalopoulou, University College London

Ms Meaghan Kall Abstract O23: Met and unmet health, welfare and social needs of people living with HIV
Ms Meaghan Kall, Public Health England

Dr Katherine Bristowe Abstract O24: A novel patient reported outcome measure for people living with HIV – development, face and content validity and stakeholder views on implementation
Dr Katherine Bristowe, King's College London


Watch video

 

Sexual Health Oral Research Presentations: Session 4

Dr Mathew Beale Abstract O25: Building a genomic framework for syphilis: novel approaches to whole genome sequencing
Dr Mathew Beale, Wellcome Sanger Institute

Dr Sonali Wayal Abstract O26: Do men who have sex with men test for STIs as per BASHH/BHIVA guidelines and what factors influence STI testing? Findings from a large online community-based survey in England
Dr Sonali Wayal, University College London

Ms Elaney Youssef Abstract O27: Clinician-related factors associated with offering HIV tests to people aged 50+: a qualitative study
Ms Elaney Youssef, Brighton and Sussex Medical School

Miss Natasha Ratna Abstract O28: A quantitative evaluation of the London Come Correct Condom Card (C-Card) scheme: does it serve those in greatest need?
Miss Natasha Ratna, Public Health England

Mr Aedan Wolton Abstract O29: Trans:mission – A community-led HIV testing initiative for trans people and their partners at a Central London sex-on-premises venue
Mr Aedan Wolton, cliniQ CIC

Miss Charlotte Towner Abstract O30: A mystery shop of genito-urinary medicine clinics evaluating the quality of advice given following a diagnosis of genital herpes type 2
Miss Charlotte Towner, University of Southampton

Miss Alicja Beksinska Abstract O31: Mapping the violence landscape among female sex workers in Karnataka, South India: associations between violence exposure by perpetrator, and HIV/STI risk
Miss Alicja Beksinska, London School of Hygiene and Tropical Medicine

Ms Eimear Haughey Abstract O32: Investigating the prevalence of non-consensual sexual experiences in a Northern Ireland university student population
Ms Eimear Haughey, SCORE

Dr Rebecca Adlington Abstract O33: Review of presentation, management and outcome of six cases of genital Neisseria gonorrhoeae in pre-pubertal girls
Dr Rebecca Adlington, Kings College Hospital NHS Foundation Trust, London


Watch video

 

BHIVA/BASHH Lunchtime Workshop 3 - Clinico-pathological case presentations workshop

Dr Ruth Harris Under pressure
Dr Ruth Harris, University Hospital Lewisham, London

Dr Nina Vora A rash decision
Dr Nina Vora, Mortimer Market Centre, London

Dr Hardeep Kang HHV-8 a diagnosis to debate
Dr Hardeep Kang, Manchester University NHS Foundation Trus

BHIVA/BASHH Lunchtime Workshop 4

Professor Claudia Estcourt Dr Jennifer Whetham Digital technologies, HIV and STIs
Professor Claudia Estcourt, Glasgow Caledonian University
Dr Jennifer Whetham, Brighton and Sussex University Hospitals NHS Trust

HIV Oral Research Presentations: Session 5

Dr Penelope Sellers Abstract O34: HIV-2 in the United Kingdom – management and antiretroviral treatment outcomes
Dr Penelope Sellers, Barts Health NHS Trust, London

Mr Richie Castles Abstract O35: Safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in HIV-infected adults on chronic haemodialysis
Mr Richie Castles, Gilead Sciences Ltd

Dr Xinzhu Wang Abstract O36: Plasma NRTI concentrations and renal function in people with HIV
Dr Xinzhu Wang, Imperial College London

Professor Chloe Orkin Abstract O37: Renal, inflammatory and bone biomarkers following switch to the DTG + RPV 2-drug Regimen: the SWORD-1 and SWORD-2 Studies
Professor Chloe Orkin, Barts Health NHS Trust, London

Dr Patrick Mallon Abstract O38: Platelet function upon switching to tenofovir alafenamide (TAF) verses continuing abacavir (ABC): A randomised substudy
Dr Patrick Mallon, University College Dublin

Dr Kate Childs Abstract O39: 5-and10-year survival in a large cohort of patients with HIV associated non-cirrhotic portal hypertension (NCPH)
Dr Kate Childs, King's College Hospital, London


Watch video

 

Sexual Health Oral Research Presentations: Session 6

Dr Jaime Vera Abstract O40: Digital vending machine technology to distribute HIV self-tests to high risk men who have sex with men
Dr Jaime Vera, Brighton and Sussex Medical School

Dr Paula Baraitser Abstract O41: Comparing uptake and acceptability of online self-sampling and self-testing for HIV
Dr Paula Baraitser, King's College Hospital, London

Dr Matthew Page Abstract O42: Are all HIV postal sampling kits the same? Dried blood spots significantly outperform conventional mini-tube sampling in a real-world comparative review
Dr Matthew Page, Birmingham Heartlands Hospital

Dr Michael Brady Abstract O43: Integrating online services with face-to-face clinics: how we successfully managed channel shift
Dr Michael Brady, Kings College Hospital NHS Foundation Trust, London

Dr Jo Gibbs Abstract O44: How do people experience negotiating HIV-related online and remote testing resources?
Dr Jo Gibbs, University College London

Mr Adam Black Abstract O45: Safeguarding young people using online sexual health services
Mr Adam Black, SH:24


Watch video

 

BHIVA/BASHH Invited Lecture 3

Dr Andreas Wismeijer Telling the truth: issues around disclosure of sexually transmitted infections
Dr Andreas Wismeijer, Tilbury University, The Netherlands


Watch video